Back
Exact Sciences 10K Form
Sell
48
EXAS
Exact Sciences
Last Price:
68.95
Seasonality Move:
15.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | EXAS/Exact Sciences Quarterly |
| 2023-11-01 | 10Q | EXAS/Exact Sciences Quarterly |
| 2023-08-01 | 10Q | EXAS/Exact Sciences Quarterly |
| 2023-05-09 | 10Q | EXAS/Exact Sciences Quarterly |
| 2022-11-03 | 10Q | EXAS/Exact Sciences Quarterly |
| 2022-08-02 | 10Q | EXAS/Exact Sciences Quarterly |
Receive EXAS News And Ratings
See the #1 stock for the next 7 days that we like better than EXAS
EXAS Financial Statistics
Sales & Book Value
| Annual Sales: | $2.5B |
|---|---|
| Cash Flow: | $71.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $17.29 |
| Price / Book: | 4.03 |
Profitability
| EPS (TTM): | -0.95570 |
|---|---|
| Net Income (TTM): | $-175.01M |
| Gross Margin: | $1.85B |
| Return on Equity: | -5.59% |
| Return on Assets: | -2.71% |
Exact Sciences Earnings Forecast
Key Exact Sciences Financial Ratios
- The Gross Profit Margin over the past 26 years for EXAS is 73.83%.
- The Selling, General & Administrative Expenses for EXAS have been equal to 64.82% of Gross Profit Margin.
- The Research & Development expenses have been 17.04% of Revenue.
- The Interest Expense is -11.96% of Operating Income.
- The Net Earning history of EXAS is -8.17% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 14 years.
Exact Sciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | EXAS |
| CUSIP: | 30063P |
| Website: | exactsciences.com |
Debt
| Debt-to-Equity Ratio: | 0.8 |
|---|---|
| Current Ratio: | 2.17 |
| Quick Ratio: | 1.81 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 390.58 |
EXAS Technical Analysis vs Fundamental Analysis
Sell
48
Exact Sciences (EXAS)
is a Sell
Is Exact Sciences a Buy or a Sell?
-
Exact Sciences stock is rated a Sell
The current Exact Sciences [EXAS] share price is $70.49. The Score for EXAS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.